Skip to main content

Table 4 Univariate analysis for CMR predictors of Major Adverse Cardiac Events

From: Cardiovascular magnetic resonance predictors of clinical outcome in patients with suspected acute myocarditis

Variables Presence of MACE at FU (N = 22) Absence of MACE at FU (N = 181) P value OR (95 % CI)
CMR Pattern    P = 0.094 2.16 (0.86–5.38)
  Nodular 13 137   
  Linear 9 44   
Wall distribution    P = 0.103  
  Subepicardial 15 153   
  Midwall 7 26   
  Transmural 0 2   
Localization    P = 0.65  
  Posterolateral 13 109   
  Septal 1 2   
  Anterior 2 15   
  Septal + posterolateral 6 54   
Presence of pericardial effusion 9 49 P = 0.18 1.86 (0.75–4.64)
Gender    P = 0.87  
  Male 137 17   
  Female 44 5   
Presence and extent of Early Gadolinium Enhancement (% myocardial surface area) 2.2 % ± 4.1 5.1 % ± 6.0 P = 0.005  
Number of segments with EGE 1.0 ± 1.7 1.9 ± 1.9 P = 0.04  
Age 47 ± 13 42 ± 17 P = 0.14 0.91 (0.32–2.62)
Presence of asynergic segments on CMR 6 33 P = 0.31 1.68 (0.61–4.62)
Presence of EGE in 2 opposed walls 3 27 P = 0.87 0.90 (0.25–3.25)
Presence of LGE in 2 opposed walls 8 69 P = 0.87 0.93 (0.37–2.32)
Myocardial extent of Late Gadolinium Enhancement (% myocardial surface area) 11.9 % ± 6.8 11.3 % ± 7.2 P = 0.72  
Number of segments with LGE 4.2 ± 2.4 3.7 ± 2.2 P = 0.41  
Presence of T2-hypersignal 8 92 P = 0.69 0.81 (0.27–2.46)
Presence of T2-hypersignal in opposed walls 2 32 P = 0.50 0.59 (0.13–2.79)
Myocardial extent of hyper T2 signal (% myocardial surface area) 4.9 ± 4.9 7.0 ± 7.0 P = 0.16  
Number of segments with hyper T2 signal 1.9 ± 1.8 1.9 ± 1.9 P = 0.9  
Initial end-diastolic LV volume, ml/m2 77 ± 22 73 ± 18 P = 0.39  
Initial LV ejection fraction, % 51.9 ± 9 57.6 ± 8.9 P = 0.009  
  1. Data are presented as mean value, ± Standard Deviation